2026-01-07 15:24:49

U.S. stocks opened mildly today: the Dow Jones Industrial Average rose slightly by 0.1%, the S&P 500 index increased by a very modest 0.03%, and the Nasdaq gained a small 0.02%. However, there are some interesting movements in individual stocks.

GameStop's stock opened with a gap up to a 3.97% increase, driven by the company's new CEO performance-based compensation plan. It seems the market is receptive to management incentive mechanisms. Such compensation structure adjustments typically influence investor expectations.

Even more explosive is the pharmaceutical sector's Ventyx, which surged by 49% at one point. The reason is rumors that Eli Lilly(, the pharmaceutical giant,) is close to finalizing a deal worth over $1 billion. When large pharmaceutical companies initiate mergers and acquisitions, it often signifies recognition of the long-term value of the target company. This signal is quite attractive to tech and biotech stocks.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

15 Likes

Reward
15
7
Repost
Share

Comment

0/400

BackrowObserver

· 01-10 07:51

Game Station has risen again and again, and this time it's really not a paper tiger... The management's big salary overhaul seems to be quite popular. I really didn't expect Ventyx's 49%, Lilly is about to make a move... When big companies step in, pharmaceutical stocks tend to get restless. However, the market's small increase is a bit awkward; individual stocks are partying while the index stays flat. This rhythm is a bit outrageous. Mergers and acquisitions in the pharmaceutical sector do tend to attract retail investors, but is the news already finalized? We need to wait for concrete evidence, everyone.

View OriginalReply0

LiquiditySurfer

· 01-07 18:13

Once again, the market is indifferent, and individual stocks are going crazy. I really like this vibe. Can GME's compensation plan really save it this time? I'm a bit skeptical. Ventyx 49% directly takes off. If Lilly really makes a move, it would be a huge profit. As soon as the big pharmaceutical acquisition signals come out, small-town youths start to rush in like they're sleepwalking. From a feeling perspective, this wave of pharmaceutical mergers and acquisitions has just begun, and there should be more to come.

View OriginalReply0

LidoStakeAddict

· 01-07 15:54

The market is so dull, we still have to rely on individual stocks to save the day. Ventyx's 49% is incredible. GameStop is up to its tricks again. How many times has the CEO compensation plan been played out like this? Lilly is planning to acquire? A billion-dollar level deal. If this deal is confirmed, the biotech and pharmaceutical sector will be excited. The market's increase is almost negligible, no wonder everyone is piling into hot topics. If Ventyx hadn't fallen through this wave, it would have made a huge profit. The rumors are not always accurate. GameStop's 3.97%, is it really all just supported by the compensation plan? The signals of mergers and acquisitions in the pharmaceutical industry are indeed strong, but such rumors usually need to be taken with a grain of salt. 49% limit-up or not? How many people are betting on Lilly's sincerity? The market's volatility ultimately depends on the biotech sector's performance.

View OriginalReply0

ContractCollector

· 01-07 15:48

Game Station is back again, with the CEO salary adjustment directly increasing by nearly 4%, really scaring the retail investors. Ventyx's 49% surge is incredible; Eli Lilly's move is a billion-dollar-level acquisition, and their attitude is quite aggressive. The market is so sluggish, it's all up to individual stocks to save the day.

View OriginalReply0

FomoAnxiety

· 01-07 15:48

The market is so weak, can we still play individual stocks? GameStop's gains are pretty good, but I'm just worried it might be a flash in the pan. Ventyx's 49% surge is crazy. If Lilly really takes over a billion-dollar acquisition... should I jump in quickly or wait for a pullback? My fear is acting up again; I always feel there's a trap behind such a rise. Large pharmaceutical companies' moves usually don't disappoint, but rumors and actual actions are two different things. When will Chinese concept stocks also pull off something like this? Just dreaming, I guess.

View OriginalReply0

UnluckyMiner

· 01-07 15:32

Wow Ventyx this wave up 49%, is Lilly going to take it over? Now that's real super profit. GameStop is also moving, the CEO's compensation changed and the stock gapped up. Some people are still buying into this pattern. The overall market isn't very strong, still need to watch these dark horses. My eyes are almost blind. Here we go again, more rumors flying around. Let's wait until it's confirmed before talking. The news is too volatile. But if the pharma sector is about to rise, we need to look carefully. Don't want to step into another trap.

View OriginalReply0

GmGmNoGn

· 01-07 15:28

GME is making moves again, a 3.97% increase just like that? But then again, can the CEO compensation plan really save it... Ventyx skyrocketed 49%, if this Lilly acquisition really hits the mark, the biotech and pharmaceutical sector is about to take off. The index only moved this much, individual stocks are the real show, the market just loves this kind of suspense. It's another round of acquisition rumors and incentive plans, the market eats this stuff up, taking advantage and then acting innocent. The pharma sector is about to go crazy again, once big acquisitions start, small investors have no chance.

View OriginalReply0